Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Efung 9th Venture Investment Center is a venture capital investment vehicle managed by Efung Capital, a leading Chinese private equity and venture capital firm. The fund is primarily dedicated to identifying and supporting innovative enterprises within the life sciences, biotechnology, and healthcare sectors. It focuses on early-to-growth stage companies, providing the necessary capital for research, development, and market expansion. The center's portfolio includes a diverse range of healthcare-related businesses, from drug discovery platforms to medical device manufacturers. Through its strategic investments, the center aims to foster technological advancement and commercialization within the Chinese healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Efung 9th Venture Investment Center.